Work

Chitosan Derivatives Associated with Ceftazidime: Study of Controlled Release and Antibacterial Activity

Year: 2025

Type: article

Abstract: , all derivatives achieved >90% inhibition. These findings indicate that the chitosan derivatives are promising materials for controlling CFZ release in gastric and intestinal environments. Furthermore, when combined with CFZ, these derivatives demonstrate significant potential for antibacterial applications against Gram-positive and Gram-negative bacteria.

Source: ACS Omega

DOI: 10.1021/acsomega.5c06901

Authors: Luizângela da Silva Reis, Roosevelt D. S. Bezerra, Humberto M. Barreto, Josy A. Osajima, Edson C. Silva-Filho

Institutions: Universidade Federal do Piauí, Instituto Federal do Piauí

Language: English

Topic: Advanced Drug Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,935